Guardant Health

Yahoo Finance • 14 hours ago

3 Growth Stocks We Think Twice About

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajec... Full story

Yahoo Finance • 6 days ago

Guardant Health (GH) Partners With Manulife to Launch Shield Multi-Cancer Detection Test in Asia

Guardant Health Inc. (NASDAQ:GH) is one of the most promising stocks under $100 to buy. On March 16, Guardant Health announced the launch of its Shield multi-cancer detection/MCD test in several Asian markets through a first-of-its-kind pa... Full story

Yahoo Finance • 8 days ago

Why Guardant Health’s (GH) 2026 Screening Story Reinforced Piper Sandler’s Bullish View

Guardant Health, Inc. (NASDAQ:GH) is one of the best growth stocks to buy according to billionaires. As of March 13, 2026, Guardant Health carried a Moderate Buy consensus from 23 analysts, based on 21 Buy ratings, one Hold, and one Sell.... Full story

Yahoo Finance • 9 days ago

Here’s Why Artisan Small Cap Fund Bets on Guardant Health (GH)

Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Small Cap Fund”. A copy of the letter can be downloaded here. The Fund seeks to invest in companies that possess franchise ch... Full story

Yahoo Finance • 11 days ago

Manulife Announces Exclusive Partnership with Guardant Health to Bring the Shield Multi-Cancer Detection Test to Customers Across Asia

First insurer in Asia to bring the innovative blood-based multi‑cancer screening solution to Hong Kong, Singapore, and the Philippines TSX/NYSE/PSE: MFC SEHK: 945 HONG KONG, SINGAPORE, and MANILA, Philippines, March 16, 2026 /PRNewswire/... Full story

Yahoo Finance • 13 days ago

This Fund Has a $200 Million Bet on a Biotech Stock Up 30% in Days After Phase 3 Breakthrough

On February 17, 2026, Driehaus Capital Management disclosed a buy of Xenon Pharmaceuticals(NASDAQ:XENE), adding 369,577 shares in an estimated $15.52 million trade based on quarterly average pricing. What happened According to an SEC fil... Full story

Yahoo Finance • 13 days ago

Battery Storage Stock Up 50% in a Year Draws New $110M Investment. Here's What You Should Know

Driehaus Capital Management disclosed a significant buy of Eos Energy Enterprises(NASDAQ:EOSE) in its February 17, 2026, SEC filing, adding 7.70 million shares in an estimated $110.72 million trade based on quarterly average pricing. What... Full story

Yahoo Finance • 21 days ago

Guardant Health Tour Highlights Colorectal Test Uptake And Valuation Gap

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Guardant Health (NasdaqGS:GH) has launched the Shield Across America mobile screening tour to pr... Full story

Yahoo Finance • 27 days ago

Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after a surprisingly hot wholesale inflation report fueled investor concerns about persistent price pressures. The Producer Price Index (PPI), a key measure of inflation at... Full story

Yahoo Finance • 28 days ago

Guardant Health (GH) Gained from Better-Than-Expected Results

Aristotle Funds, an investment advisor, released its “Growth Equity Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S. equity markets reached new all-time highs in Q4 2025, with the S&P 500 Index r... Full story

Yahoo Finance • last month

What Makes Guardant Health (GH) a Good Healthcare Holding

Carillon Tower Advisers, an investment management company, released its fourth-quarter 2025 investor letter for the “Carillon Eagle Small Cap Growth Fund”. You can download a copy of the letter here. Small-cap stocks delivered marginal gai... Full story

Yahoo Finance • 2 months ago

Merck Deepens Oncology And Vaccine Bets With Partnerships And Equity Stake

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Merck (NYSE:MRK) has taken a significant equity stake in Eikon The... Full story

Yahoo Finance • 2 months ago

Merck Eyes Post Keytruda Growth With Eikon Stake And Guardant Pact

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Merck (NYSE:MRK) has invested $30 million for nearly a 10% stake in Eikon Therapeutics as Eikon mo... Full story

Yahoo Finance • 3 months ago

Canaccord Names Guardant Health (GH) Top Life Science Pick, Cites Strong Growth and Low Downside

Guardant Health Inc. (NASDAQ:GH) is one of the hottest large-cap stocks of 2025. On December 22, Canaccord raised the firm’s price target on Guardant Health to $125 from $100 with a Buy rating on the shares. The firm expects the life scien... Full story

Yahoo Finance • 3 months ago

Guardant Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

PALO ALTO, Calif., December 29, 2025--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the upcoming 44th Annual J.P. Morgan Healthcare Conference in... Full story

Yahoo Finance • 3 months ago

Noteworthy ETF Outflows: ARKG, TEM, TWST, GH

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ARK Genomic Revolution ETF (Symbol: ARKG) where we have detected an approximate $73.5 million dollar outflow... Full story

Yahoo Finance • 3 months ago

Tuesday's ETF Movers: ARKF, XT

In trading on Tuesday, the ARK Fintech Innovation ETF is outperforming other ETFs, up about 1.2% on the day. Components of that ETF showing particular strength include shares of Circle Internet Group, up about 8.6% and shares of Robinhood... Full story

Yahoo Finance • 3 months ago

Guardant Health price target raised to $120 from $100 at BofA

BofA raised the firm’s price target on Guardant Health (GH) to $120 from $100 and keeps a Buy rating on the shares. The firm is updating it price targets for Life Sciences & Diagnostic Tools stocks under its coverage, the analyst tells inv... Full story

Yahoo Finance • 4 months ago

AI adopters trade gaining steam; top stocks in AI adoption sectors

[Digital Intelligence - AI Icon Illuminated Against Financial Data and Binary Streams] J Studios Wall Street research looks to be shifting from endorsing the classic AI trade to AI adopters. Instead of the chipmakers and hyperscalers in... Full story

Yahoo Finance • 4 months ago

LLY joins $1T club but doesn't feature in SA's top 10 large-cap healthcare stocks

[Lilly Biotechnology Center in San Diego, California, USA.] JHVEPhoto Eli Lilly (LLY [https://seekingalpha.com/symbol/LLY]) officially joined the elite group of U.S. companies valued at more than $1T on Friday, becoming the tenth American... Full story